Clinical Trial Update: Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating QLH12016 in combination with a novel hormonal agent for advanced prostate cancer, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Novel Hormonal Agent
• QLH12016

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING